Literature DB >> 12713526

Depressed mood and executive dysfunction in early Parkinson's disease.

J Uekermann1, I Daum, S Peters, B Wiebel, H Przuntek, T Müller.   

Abstract

OBJECTIVES: Studies on neuropsychological functions in early Parkinson's disease (PD) have reported changes with respect to memory and executive control related to dysfunction of fronto-striatal circuitry. The question has been raised, however, whether these findings are at least partly influenced by depression, which as such can also lead to cognitive impairments that depend on the functional integrity of the prefrontal cortex.
MATERIAL AND METHODS: In the present investigation early non-depressed PD patients (NPD), early PD patients with mild depressive symptoms (DPD), patients with primary depression (DEP) and healthy controls (HC) completed a range of neuropsychological tests.
RESULTS: Group comparisons revealed impairments of DPD patients in comparison with HC with respect to verbal fluency, short-term memory and concept formation. In addition they showed mild working-memory deficits.
CONCLUSIONS: In summary the present results indicate that depressed mood in early PD may exacerbate cognitive impairments. Thus careful assessment of affective variables in PD should be an integral part of the treatment of PD.

Entities:  

Mesh:

Year:  2003        PMID: 12713526     DOI: 10.1034/j.1600-0404.2003.02155.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

1.  Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Authors:  Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Katia Longo; Autilia Cozzolino; Dario Grossi; Paolo Barone
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

2.  Dopaminergic modulation of memory and affective processing in Parkinson depression.

Authors:  Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt
Journal:  Psychiatry Res       Date:  2013-07-06       Impact factor: 3.222

3.  Occurrence of depression and anxiety prior to Parkinson's disease.

Authors:  E L Jacob; N M Gatto; A Thompson; Y Bordelon; B Ritz
Journal:  Parkinsonism Relat Disord       Date:  2010-08-01       Impact factor: 4.891

4.  The relation of anxiety and cognition in Parkinson's disease.

Authors:  Gretchen O Reynolds; Kristine K Hanna; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychology       Date:  2017-04-20       Impact factor: 3.295

5.  Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease.

Authors:  Paul Ardayfio; Jisook Moon; Ka Ka Amanda Leung; Dong Youn-Hwang; Kwang-Soo Kim
Journal:  Neurobiol Dis       Date:  2008-06-04       Impact factor: 5.996

6.  Comparison of 200 mg retarded release levodopa/carbidopa - with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson's disease.

Authors:  T Müller; L Ander; K Kolf; D Woitalla; S Muhlack
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

7.  Cognitive impairment in Parkinson's disease without dementia: subtypes and influences of age.

Authors:  Jae Woo Kim; Sang Myung Cheon; Min Jeong Park; Seong Yeon Kim; Hee Young Jo
Journal:  J Clin Neurol       Date:  2009-09-30       Impact factor: 3.077

8.  Major life events and development of major depression in Parkinson's disease patients.

Authors:  N H Rod; Y Bordelon; A Thompson; E Marcotte; B Ritz
Journal:  Eur J Neurol       Date:  2012-10-30       Impact factor: 6.089

9.  Are verbal fluency and nonliteral language comprehension deficits related to depressive symptoms in Parkinson's disease?

Authors:  Christina Tremblay; Oury Monchi; Carol Hudon; Joël Macoir; Laura Monetta
Journal:  Parkinsons Dis       Date:  2012-02-12

10.  Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study.

Authors:  R Scott Mackin; Patricia Areán; Alexandra Elite-Marcandonatou
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.